Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 18/20 | 0.37 |
| ▸ | AKT2 | P31751 | 3/20 | 0.37 |
| ▸ | AKT3 | Q9Y243 | 3/20 | 0.37 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.31 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL473313 | 0.79 | AKT1 (0.41) | AKT1AKT2AKT3ROCK2RPS6KB1 | |
| SCHEMBL23532317 | 0.71 | AKT1 (0.54) | AKT1AKT2AKT3ROCK2KCNH2 | |
| SCHEMBL473310 | 0.69 | RPS6KB1 (0.52) | AKT1AKT2AKT3ROCK2RPS6KB1 | |
| SCHEMBL473308 | 0.67 | AKT1 (0.46) | AKT1AKT2RPS6KB1 | |
| SCHEMBL10159516 | 0.66 | AKT1 (0.38) | AKT1AKT2AKT3 | |
| SCHEMBL2299211 | 0.66 | RPS6KB1 (0.56) | AKT1AKT2RPS6KB1 | |
| SCHEMBL23532315 | 0.65 | AKT1S1 (0.59) | AKT1AKT2AKT3RPS6KB1 | |
| SCHEMBL473355 | 0.64 | AKT1 (0.43) | AKT1AKT2AKT3ROCK2KCNH2 | |
| SCHEMBL473298 | 0.63 | AKT1 (0.43) | AKT1AKT2AKT3ROCK2KCNH2 | |
| SCHEMBL473351 | 0.62 | RPS6KB1 (0.54) | AKT1AKT2AKT3ROCK2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1848719-A1 | [1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YL]-PIPERIDINE OR -PIPERAZINE COMPOUNDS AS SERINE-THREONINE KINASE MODULATORS (P70S6K, ATK1 AND ATK2) FOR THE TREATMENT OF IMMUNOLOGICAL, INFLAMMATORY AND PROLIFERATIVE DISEASES | Exelixis, Inc. (US) | 2007-10-31 | — | — | EP | disclosed |
| WO-2006071819-A1 | [1H-PYRAZOLO[3, 4-D]PYRIMIDIN-4-YL]-PIPERIDINE OR -PIPERAZINE COMPOUNDS AS SERINE-THEORONINE KINASE MODULATORS (P70S6K, ATK1 AND ATK2) FOR THE TREATMENT OF IMMUNOLOGICAL, INFLAMMATORY AND PROLIFERATIVE DISEASES | EXELIXIS, INC. (US) | 2006-07-06 | — | — | WO | disclosed |